Q2 2022 Holdings
Filed 2022-08-15 | 23 holdings | $114.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $40.2M | 432,170 | 35.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $33.7M | 88,816 | 29.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $21.8M | 517,406 | 19.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $17.6M | 1,048,516 | 15.4% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $552.0K | 73,149 | 0.5% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $53.8K | 978,596 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $46.2K | 1,445,566 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $44.3K | 659,968 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $44.1K | 801,314 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $42.2K | 556,043 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $38.4K | 163,066 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $24.9K | 667,417 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.9K | 876,156 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $15.1K | 1,306,569 | 0.0% |
| Merus N V | COM | N5749R100 | $10.2K | 452,244 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $9.0K | 1,408,050 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.4K | 1,964,709 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.0K | 826,779 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $7.0K | 148,216 | 0.0% |
| VOR Biopharma Inc | COM | 929033108 | $6.5K | 1,304,300 | 0.0% |
| Oyster PT Pharma Inc | COM | 69242L106 | $5.8K | 1,333,330 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $4.3K | 783,445 | 0.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.7K | 850,961 | 0.0% |